Dale A. Sander, CFO and Chief Corporate Deve. Officer at Humacyte, Inc. (HUMA), sold 78,778 shares at $6.68 ($526K) on 2024-08-27, disclosed to the SEC on 2024-08-29.
Open-market sale of $526k HUMA by CFO and Chief Corporate Deve. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.68 | 39,389 | $263K | 50.0% |
| 2 | $6.68 | 39,389 | $263K | 50.0% |
| Total | $6.68 avg | 78,778 | $526K | 100% |
| Filing → |
| HUMA | BUY | 2022-12-19 | $52K | — | Filing → |
| HUMA | BUY | 2022-05-18 | $9K | — | Filing → |